2.53
Precedente Chiudi:
$2.66
Aprire:
$2.65
Volume 24 ore:
892.24K
Relative Volume:
0.70
Capitalizzazione di mercato:
$277.57M
Reddito:
-
Utile/perdita netta:
$-134.24M
Rapporto P/E:
-1.4294
EPS:
-1.77
Flusso di cassa netto:
$-121.34M
1 W Prestazione:
-5.60%
1M Prestazione:
-15.95%
6M Prestazione:
-64.86%
1 anno Prestazione:
-56.15%
Annexon Inc Stock (ANNX) Company Profile
Nome
Annexon Inc
Settore
Industria
Telefono
(650)-822-5500
Indirizzo
1400 SIERRA POINT PARKWAY, BRISBANE
Confronta ANNX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ANNX
Annexon Inc
|
2.53 | 277.57M | 0 | -134.24M | -121.34M | -1.77 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 129.14B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 74.41B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
581.21 | 35.31B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
254.57 | 27.35B | 3.32B | -860.46M | -1.04B | -8.32 |
Annexon Inc Stock (ANNX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-03-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
2023-12-21 | Aggiornamento | BofA Securities | Neutral → Buy |
2023-10-30 | Iniziato | Wells Fargo | Overweight |
2023-05-26 | Downgrade | BofA Securities | Buy → Neutral |
2023-05-25 | Downgrade | JP Morgan | Overweight → Neutral |
2022-09-16 | Iniziato | Jefferies | Buy |
2022-09-09 | Iniziato | BTIG Research | Buy |
2021-11-30 | Iniziato | H.C. Wainwright | Buy |
2021-09-23 | Iniziato | Cantor Fitzgerald | Overweight |
2021-01-26 | Iniziato | Needham | Buy |
2020-08-18 | Iniziato | BofA Securities | Buy |
2020-08-18 | Iniziato | Cowen | Outperform |
2020-08-18 | Iniziato | JP Morgan | Overweight |
Mostra tutto
Annexon Inc Borsa (ANNX) Ultime notizie
Annexon: Despite Major Catalysts, Stock Is Trading Almost At Cash (NASDAQ:ANNX) - Seeking Alpha
Annexon, Inc. (NASDAQ:ANNX) Given Average Rating of “Buy” by Analysts - Defense World
Rhumbline Advisers Purchases 5,854 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World
Q1 Earnings Forecast for Annexon Issued By HC Wainwright - Defense World
Annexon Biosciences: Promising Developments and Strategic Milestones Justify Buy Rating - TipRanks
Analysts Set Expectations for Annexon FY2025 Earnings - Defense World
Q2 Earnings Estimate for Annexon Issued By HC Wainwright - Defense World
New York State Common Retirement Fund Purchases 20,311 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World
Potential Price Increase for Annexon Inc (ANNX) After Recent Insider Activity - Knox Daily
Annexon stock price target cut to $20 at H.C. Wainwright By Investing.com - Investing.com Canada
Annexon (NASDAQ:ANNX) Given “Buy” Rating at Needham & Company LLC - Defense World
Gaining Ground: Annexon Inc (ANNX) Closes Lower at 2.39, Down -9.47 - The Dwinnex
Promising Developments in Annexon Biosciences’ Pipeline Drive Buy Rating - TipRanks
Annexon Biosciences Reports Strong Progress in 2024 - MSN
Annexon Reports Fourth Quarter and Year-End 2024 Financial Results, Portfolio Progress and Key Anticipated Milestones - The Manila Times
Annexon reports Q4 EPS (33c), consensus (29c) - TipRanks
Annexon Reports Fourth Quarter and Year-End 2024 Financial - GlobeNewswire
Can Annexon's $312M War Chest Fuel Its Breakthrough Treatments Through 2026? - StockTitan
Annexon stock hits 52-week low at $2.63 amid market challenges - Investing.com Australia
Annexon Biosciences to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewswire
What Will Annexon Reveal at the TD Cowen Healthcare Conference Next Week? - StockTitan
Annexon stock hits 52-week low at $2.63 amid market challenges By Investing.com - Investing.com South Africa
Annexon stock hits 52-week low at $3.04 amid market challenges - MSN
Annexon, Inc. (NASDAQ:ANNX) CEO Sells $14,811.95 in Stock - MarketBeat
Annexon executive sells shares worth $16,379 By Investing.com - Investing.com South Africa
Annexon EVP Ted Yednock sells $24,283 in stock - Investing.com India
Annexon chief medical officer sells $16,342 in common stock By Investing.com - Investing.com South Africa
Annexon chief medical officer sells $16,342 in common stock - Investing.com
Annexon chief business officer sells $19,523 in company stock By Investing.com - Investing.com Australia
Annexon executive sells shares worth $16,379 - Investing.com
Annexon chief business officer sells $19,523 in company stock - Investing.com
Annexon CFO Jennifer Lew sells shares worth $20,183 By Investing.com - Investing.com South Africa
Annexon CFO Jennifer Lew sells shares worth $20,183 - Investing.com
Annexon CFO Jennifer Lew Sells Shares to Cover Tax Obligations - TradingView
Annexon, Inc. (NASDAQ:ANNX) Short Interest Update - MarketBeat
Annexon, Inc. (NASDAQ:ANNX) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Annexon EVP sells $4,260 in stock to cover tax obligations - Investing.com India
Annexon EVP sells $4,260 in stock to cover tax obligations By Investing.com - Investing.com Canada
Annexon EVP Ted Yednock sells $5,331 in stock By Investing.com - Investing.com Canada
Annexon CFO Jennifer Lew sells $5,322 in stock By Investing.com - Investing.com South Africa
Annexon EVP Ted Yednock sells $5,331 in stock - Investing.com
Annexon CFO Jennifer Lew sells $5,322 in stock - Investing.com
Annexon CEO Love Douglas sells $14,811 in stock - Investing.com
Annexon CEO Love Douglas sells $14,811 in stock By Investing.com - Investing.com South Africa
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Annexon Inc Azioni (ANNX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):